Rolph Timothy bought AKRO
September 8, 2025 · Form 4 insider transaction
Rolph Timothy bought 5,161 shares of Akero Therapeutics, Inc. at $6.36 per share, a transaction worth $32.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,161
Price
$6.36
Total value
$32.8K
InsiderRolph Timothy
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 8, 2025
Filing dateSeptember 10, 2025
Shares owned after179,329
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 12, 2024, previously adopted by the Reporting Person.